Tissue sialic acid and fibronectin levels in human prostatic cancer

Cancer Letters

Volumn 99, Issue 2, 1996, Pages 135-137

  Suer S ^a   Sonmez H ^a   Karaaslan, I ^a   Baloglu H ^b   Kokoglu E ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Fibronectin; Human prostatic cancer; Sialic acid; Tumor marker

Indexed keywords

FIBRONECTIN; PROSTATE PROTEIN; SIALIC ACID;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TISSUE LEVEL;

EID: 17144454454     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(95)04084-6     Document Type: Article

References (34)

1. Akiyama, S., Yamada, K. and Hayashi, M. (1981) The structure of fibronectin and its role in cellular adhesion. J Supramol. Struct. Cell Biochem., 16, 345-358.
2. Boccardo, F., Guarneri, O., Zanardi, S., Castellani, P., Borsi, L. and Zardi. L. (1986) Fibronectin concentration in the plasma of patients with malignant and benign breast disease. Cancer Lett., 33, 317-323.
3. Eijan, A.M., Puricelli, L., Joffe, E.B., Entin, D., Vuoto, D., Orlondo, E. and Lustig, E.S. (1986) Serial analysis of fibronectin concentration in plasma of patients with benign and malignant breast diseases. Cancer, 57, 1345-1349.
4. Evans, I.M., Hiey, R., Murphy, M. and Bosmann, B. (1980) N-Acetylneuraminic acid transferase activity with growth of the R3230 AL mammary tumor in rats and relationship of the serum activity to tumor burden. Cancer Res., 40, 3103-3111.
5. Gallurt, P., Rodriguez, P., Lorenzo, A., Lopezsaes, J.J., Senra, A. and Millan, J. (1992) Plasmatic fibronectin in malignancies. Int. J. Biol. Markers, 7, 240-243.
6. Gatchev, O., Rastam, L., Lindberg, G., Gullberg, B., Eklund, G. A. and Törnberg, S. (1993) Tumours of the central nervous system and serum sialic acid concentration in men and women. Br. J. Cancer, 68, 425-427.
7. Henderson, W. and Kessel, D. (1977) Alteration in plasma sialytransferase levels in patients with neoplastic disease. Cancer, 38, 1129-1134.
8. Horgan, I.E. (1982) Total and lipid-bound sialic acid in sera from patients with cancer. Clin. Chim. Acta, 118, 327-331.
9. Humphries, M.J., Obara, M., Olden, K. and Yamada, K.M. (1989) Role of fibronectin in adhesion, migration and metastasis. Cancer Invest., 7, 373-393.
10. Kageyama, T., Ohyabult, H. and Ohshiba, S. (1989) Variation of plasma fibronectin levels in leukemia patients. Bull. Osaha Med. Coll., 35, 71-76.
11. Kessel, D. Samson, N.K., Shah, S., Allen, J. and Baker, L.H. (1976) Alterations in plasma sialytransferase associated with successful chemotherapy of a disseminated tumor. Cancer, 38, 2132-2134.
12. Khanderia, U., Keller, J. and Grossman, B.I. (1983) Serum sialic acid is a biological marker for malignant disease. J. Surg. Oncol., 23, 163-166.
13. Kharrasov, A.F., Satina, N.A., Moroz, I.P. and Zinkevich, O.F. (1991) Level of plasma fibronectin and its biological activity in patients with ovarian cancer. Vopr. Onkol., 37, 572-576.
14. Kökoǧlu, E., Sönmez, H., Uslu, E. and Uslu, I. (1992) Sialic acid levels in various types of cancer. Cancer Biochem Biophys., 13, 57-64.
15. Kökoǧlu, E., Süer, S., Özyurt, E., Siyahhan, A. and Sönmez, H. (1995) Plasma fibronectin and sialic acid levels in various types of human brain tumors. Cancer Biochem. Biophys., 1-6, in press.
16. Lehninger, A.L. (1975) Biochemistry, 2nd edn., pp. 650-651. Worth Publishers, New York.
17. Lowry, O.H., Rosebrough, N.J., Farr, A.C. and Randall, R.J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265.
18. Mabry, E.W. and Carubelli, R. (1972) Sialic acid in human cancer. Experientia, 28, 182-183.
19. Marth, E., Flaschka, G., Stiegler, S. and Möse, J.R. (1988) Sialic acid as a marker for differentiation between benign and malignant intracranial tumors. Clin. Chim. Acta, 176, 251-258.
20. Mosesson, M.W. and Amrani, D.L. (1980) The structure and biological activities of plasma fibronectin. Blood, 56, 145-158.
21. Mosher, D. and Williams, E. (1978) Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J. Lab. Clin. Med., 91, 729-735.
22. Mosher, D.F. (1980) Fibronectin, In: Progress in Hemostasis and Thrombosis, Vol. 5, pp. 111-151. Editor: T.H. Spaet. Grune and Stratton, New York.
23. Plucinsky, M., Riley, M., Prorok, J. and Alhadeff, J. (1986) Total and lipid-associated serum sialic acid levels in cancer patients with differing degrees of metastatic involvement. Cancer, 58, 2680-2685.
24. Potazman, J.P., Doussal, V., Pouillard, J., Jallars, L. and Robert, J.L. (1988) Plasma fibronectin in mammary and uterine carcinomas. Clin. Physiol. Biochem., 6, 12-20.
25. Rennard, S.I. and Crystal, R.G. (1981) Fibronectin in human bronchopulmonary lavage fluid: elevation in patients with interstitial lung disease. J. Clin. Invest., 69, 113-122.
26. Reutter, W., Köttgen, W., Baver, C. and Geork, W. (1982) Sialic acids: chemistry, metabolism and function. In: Cell Biology Monograph, Vol. 10, pp. 263-305. Editor: R. Schaver. Springer, Berlin.
27. Ronquist, G. and Nov, E. (1983) Serum sialytransferase and fucosyltransferase activities in patients with bronchial carcinoma. Cancer, 52, 1674-1683.
28. Shamberger, R.J. (1984) Serum sialic acid in normals and in cancer patients. J. Clin. Chem. Clin. Biochem., 22, 647-651.
29. Singhal, A. and Hakomori, S. (1990) Moleculer changes in carbohydrate antigens associated with cancer. Bioessays, 12, 223-230.
30. Siri, A., Carnemolla, B., Raffanti, S., Castellani, P., Balzano, E. and Zardi, L. (1984) Fibronectin concentration in pleural effusions patients with malignant and non-malignant diseases. Cancer Lett., 22, 1-9.
31. Tedd, H.D., Coffee, M.S., Waalkes, T.P., Abeloff, M.D. and Parsons, R.G. (1980) Serum levels of fibronectin and fibronectin like DNA-binding protein in patients with various diseases. J. Natl. Cancer Inst., 65, 901-904.
32. Warren, L. (1959) The thiobarbituric acid assay of sialic acids. J. Biol. Chem., 234, 1971-1975.
33. Webb, K. and Lin, G. (1980) Urinary fibronectin: potential as a biomarker in prostatic cancer. Invest. Urol., 17, 401-404.
34. Weiss, J.F., Morantz, R.A., Bradley, W.P. and Chretien, P.B. (1979) Serum acute-phase proteins and immunoglobulins in patients with gliomas. Cancer Res., 39, 542-544.